Tag: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
FDA Requiring Labeling Changes to NSAIDs Warning of Risks in Pregnancy
Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later
Review IDs Dietary Factors Linked to Lower CRC Incidence
Incidence up with frequent alcohol or meat consumption; no evidence of protective effect found for tea, coffee
ACP, AAFP Issue Guidelines for Acute Musculoskeletal Injuries
Acute pain from non-low back, musculoskeletal injuries first should be treated with topical NSAIDs
Ibuprofen Does Not Increase Postpartum Blood Pressure
NSAIDs do not up postpartum BP in women with hypertensive disorders of pregnancy and mild HTN
ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients
Benefit not significant for aspirin use in patients with non-small cell lung cancer undergoing SBRT
NSAIDs Contribute to Increased CVD Risk in Osteoarthritis
Considerable proportion of increased CHF, IHD, and stroke risk mediated by NSAID use
Anti-Inflammatory Add-On May Be Beneficial for Depression
Anti-inflammatory agents improve depressive symptoms versus placebo as add-on in MDD
Increased Cardiovascular Risk for Diclofenac Initiators
Increased risk compared with NSAID non-initiators, initiators of acetaminophen, ibuprofen, naproxen
Multiple Factors to Consider When Selecting NSAID for Arthritis
Effectiveness, concurrent health conditions, and frequency of use of NSAID should be considered
NSAID Use Linked to A-Fib Risk in Middle-Aged Asian Population
Risk up with use of non-selective NSAIDs and combined use of selective, non-selective NSAIDs